Responsibilities:
Uses an analytical approach and independent judgment to resolves complex technical challenges and develop innovative solutions that consistently deliver quality IT solutions.
Design SharePoint solutions that align with business needs. Create information architecture, site structures, and workflows. Decide on the appropriate use of SharePoint features and capabilities.
Write code and develop custom solutions using SharePoint technologies, including SharePoint Designer, SharePoint Framework (SPFx), and Visual Studio. Customize SharePoint sites and pages using web parts, lists, and libraries.
Integrate SharePoint with other systems and applications within the organization. This may involve connecting to external databases, APIs, or third-party tools.
Customize SharePoint sites and pages using CSS, JavaScript, and other web development technologies to enhance the user experience and meet specific design requirements.
Develop and implement workflows using SharePoint Designer or Microsoft Power Automate (formerly known as Flow) to automate business processes and approvals.
Collaborate with other team members to implement feedback on pull request reviews.
Continuously collaborate with Product Owner to demo developed functionality and validate against specified requirements.
Ensure high performance for global users through performance tests and tuning.
Collaborate with agile team members to craft clear user stories and continuously deliver product increments.
Estimate work based on user stories and functional requirements or wireframes.
Contribute to Takeda’s mission by leading the development and adoption of solutions that deliver business outcomes and drive innovation.
Write unit and integration tests for all application code.
Leverage GitHub for CI/CD for all application development.
Skills and Qualifications:
Bachelor’s degree in computer science, systems analysis, product management or a related study, or equivalent experience.
3+ years of experience developing and administering software built on top of SharePoint & Office365.
Hands-on knowledge of key SharePoint relevant programming languages and frameworks: C#, JavaScript/TypeScript, React, SharePoint Framework (SPFx), HTML/CSS
Solid Power Platform development experience.
Hands-on experience developing complex solutions against relational databases.
Ability to communicate complex technical concepts.
Self-starter with a passion for taking ownership of your work and delivering outcomes.
Ability to continuously enhances own skills.
Strong communication skills, a team player with a 'winning as a team' attitude.
Ability to write and speak in the English language.
Practice efficient time management and coordinates tasks, working in an international environment.
With some American and British ancestry, Takeda Pharmaceutical corporation Limited is a worldwide pharmaceutical corporation based in Japan. After Sinopharm and Shanghai Pharmaceuticals, it is the third-biggest pharmaceutical firm in Asia. Based on revenue, it is among the top 20 pharmaceutical companies globally (it was in the top 10 after its merger with Shire). The corporation, which employs more than 49,578 people globally, brought in US$19.299 billion in sales in the 2018 fiscal year. The company's areas of expertise include neuroscience, gastrointestinal, oncology, uncommon disorders, plasma-derived medicines, and vaccinations. Its office is in Nihonbashi, Chuo, Tokyo, and its headquarters are in Chuo-ku, Osaka.
Takeda purchased Amgen's Japanese business in February 2008 along with the rights to twelve of the California biotechnology company's pipeline candidates for the Japanese market. Takeda paid US$8.8 billion in April to acquire Cambridge, Massachusetts-based Millennium Pharmaceuticals, a business that specializes in cancer medication development. Velcade, a medication approved for hematological malignancies, and a portfolio of pipeline prospects in the therapeutic domains of cardiovascular, inflammatory, and cancer were acquired as part of the deal. Currently, Millennium functions as a stand-alone subsidiary. The firms formed a potentially long-term agreement in May when the company licensed the RNAi technology platform created by Alnylam Pharmaceuticals on a non-exclusive basis.